Advertisement
With more than a fifty-year history, the China Import and Export Fair isone of the most well attended trade shows in China, and it boasts the widestarray of products from around the globe. This year, there were more than300,000 people attending the trade show, representing industries as diverse asclothing, chemicals, computers, auto, foods, electronics, energy, appliances,drinks, pharmaceuticals and machinery. Among the 300,000 attendees, about200,000 came from 213 countries outside of China. The China Import and ExportFair is considered by many businesses to be the most effective exhibition inChina, as it generates a high volume of transactions.
Advertisement
At the trade show, Renhuang presented its leading branded drugsAcanthopanax (Siberian Ginseng) and Tianma Headache Relief Pills. Acanthopanax,extracted from natural plants for the treatment of sleep disorders anddepression, is highly popular with the overseas distributors. The Company'sbooth attracted more than 1,500 visitors. Among them, over 500 distributorshave expressed strong interest in licensing and distributing the Company'sproducts. The Company is in discussion with about 100 distributors aspotential distribution partners and to date has already signed three lettersof intent for distribution collaborations.
"We are excited that our products were so highly regarded at the ChinaImport and Export Fair. This speaks to our strong brand name recognition andstrong worldwide customer demand. We intend to continue with our strategy ofdeveloping high quality products and expanding our presence in the overseasmarket," said Mr. Shao-ming Li, Chairman and CEO of Renhaung Pharmaceuticals,Inc.
About Renhuang Pharmaceuticals, Inc.
Founded in 1996, Renhuang Pharmaceuticals, Inc, produces Western,traditional Chinese medicines (TCM), and branded pharmaceuticals, using itsGMP-certified facilities in China. The Company's GMP-certified manufacturingfacilities, containing cutting-edge technologies and advance equipment, arecapable of producing a many as 200 types of pharmaceuticals. Additionally,Renhuang distributes raw materials and finished pharmaceuticals using itsbroad distribution channels and third party distributors throughout China. TheCompany's distribution network includes over 3,000 sales representatives in 70sales centers across 24 districts, covering over 50% of the greater China. TheCompany also exports its products to Russia and Southeast Asia. For moreinformation, visit http://www.renhuang.com .
Safe Harbor Statement
This press release contains certain statements that may include'forward-looking statements' as defined in the Securities Act of 1933, and theSecurities Exchange Act of 1934. All statements, other than statements ofhistorical facts, included herein are 'forward-looking statements'. Althoughthe Company believes that the expectations reflected in these forward-lookingstatements are reasonable, they do involve assumptions, risks anduncertainties, and these expectations may prove to be incorrect. You shouldnot place undue reliance on these forward-looking statements, which speak onlyas of the date of this press release.
The Company's actual results could differ materially from thoseanticipated in these forward-looking statements as a result of a variety offactors, including those discussed in the Company's periodic reports that arefiled with and available from the Securities and Exchange Commission. Allforward-looking statements attributable to the Company or persons acting onits behalf are expressly qualified in their entirety by t
